We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+41.46%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$475M
AUM Growth
+$69.8M
Cap. Flow
+$35M
Cap. Flow %
7.37%
Top 10 Hldgs %
76.47%
Holding
120
New
20
Increased
25
Reduced
35
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 8.75%
2 Healthcare 8.54%
3 Communication Services 3.59%
4 Consumer Discretionary 3.12%
5 Industrials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$453B
$217M 45.68%
1,464,500
+734,500
+101% +$105M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$43.5M 9.17%
292,500
-82,500
-22% -$11.6M
AAPL icon
3
CALL
Apple
AAPL
$4.54T
$31.1M 6.56%
800,000
MRNS
4
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$15.8M 3.32%
671,212
+479,600
+250% +$5.38M
HIMX
5
CALL
Himax Technologies
HIMX
$2.19B
$14.1M 2.97%
1,488,500
+750,000
+102% +$6.81M
HIMX
6
Himax Technologies
HIMX
$2.19B
$14.1M 2.96%
1,286,600
+576,600
+81% +$5.23M
META icon
7
Meta Platforms (Facebook)
META
$1.42T
$9.99M 2.1%
58,450
+26,850
+85% +$4.48M
ADMS
8
DELISTED
Adamas Pharmaceuticals
ADMS
$7.06M 1.49%
333,515
+70,000
+27% +$1.28M
AXGN icon
9
Axogen
AXGN
$2.27B
$5.3M 1.12%
273,751
-21,600
-7% -$363K
LITE icon
10
Lumentum
LITE
$55.5B
$5.29M 1.11%
97,300
+12,000
+14% +$698K
SBBP
11
DELISTED
Strongbridge Biopharma plc.
SBBP
$3.92M 0.83%
567,895
-1
-0% -$7
GOOS
12
Canada Goose Holdings
GOOS
$872M
$3.6M 0.76%
175,000
+155,000
+775% +$2.95M
GLNG icon
13
Golar LNG
GLNG
$5B
$3.28M 0.69%
145,000
+115,000
+383% +$2.53M
NVDA icon
14
NVIDIA
NVDA
$4.86T
$3.04M 0.64%
680,000
+364,000
+115% +$1.51M
SMMT icon
15
Summit Therapeutics
SMMT
$10.4B
$3.03M 0.64%
242,113
+125,000
+107% +$1.62M
MB
16
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$2.9M 0.61%
112,200
+5,900
+6% +$146K
NTES icon
17
NetEase
NTES
$85.3B
$2.58M 0.54%
49,000
+8,500
+21% +$488K
NVRO
18
DELISTED
NEVRO CORP.
NVRO
$2.55M 0.54%
28,100
-3,900
-12% -$334K
NPTN
19
DELISTED
NEOPHOTONICS CORP
NPTN
$2.55M 0.54%
458,302
+36,998
+9% +$250K
CLVS
20
DELISTED
Clovis Oncology, Inc.
CLVS
$2.53M 0.53%
30,700
-9,300
-23% -$737K
AMD icon
21
Advanced Micro Devices
AMD
$776B
$2.52M 0.53%
197,550
+47,550
+32% +$620K
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
$2.42M 0.51%
49,800
-12,159
-20% -$663K
MYND
23
Mynd.ai
MYND
$18M
$2.28M 0.48%
+8,000
New +$2.12M
ZGNX
24
DELISTED
Zogenix, Inc.
ZGNX
$2.25M 0.47%
+64,100
New +$870K
JPM icon
25
JPMorgan Chase
JPM
$935B
$2.24M 0.47%
23,500
-11,500
-33% -$1.06M

Similar funds

Granite Point Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Granite Point Capital Management held 120 positions worth $475M, up 17% from $405M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Granite Point Capital Management deployed $35M of net new capital in Q3 2017, opening 20 new positions and adding to 25 existing holdings. Its largest new stake was Mynd.ai: 8,000 shares worth $2.28M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.9% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Alibaba, an estimated $6.47M trimmed.

  • Granite Point Capital Management's largest Q3 2017 buy was Mynd.ai: 8,000 shares worth $2.28M.
  • Granite Point Capital Management added most to Marinus Pharmaceuticals, Inc in Q3 2017, an estimated $5.38M increase.
  • Granite Point Capital Management's biggest Q3 2017 reduction was Alibaba, cutting an estimated $6.47M.
  • Granite Point Capital Management fully exited NextDecade in Q3 2017, selling an estimated $3.13M.
  • Granite Point Capital Management's ten largest holdings make up 76% of its $475M portfolio in Q3 2017.
  • Granite Point Capital Management opened 20 new positions and closed 22 in Q3 2017.
  • Granite Point Capital Management's portfolio value rose 17% quarter-over-quarter to $475M.

Based on Granite Point Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.